ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

Oncologist Pans Breast Cancer Conference In Russian Heartland

August 19, 1994

No Benefit For Radiation For Early Stage Disease Spread To Only One Node

March 26, 2010

“Confidential and Proprietary” Document Proposes Plan for National Network

February 7, 2014

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

Only Three Of 28 CCRU, CCSP Proposals Approved, But DRCCA Will Try Again, Board OKs New RFAs

May 13, 1983

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993